Breakthrough invasive fungal infections: Who is at risk?

Jeffrey D. Jenks, Oliver A. Cornely, Sharon C.A. Chen, George R. Thompson, Martin Hoenigl

Resultado de la investigación: Review articlerevisión exhaustiva

61 Citas (Scopus)


The epidemiology of invasive fungal infections (IFIs) in immunocompromised individuals has changed over the last few decades, partially due to the increased use of antifungal agents to prevent IFIs. Although this strategy has resulted in an overall reduction in IFIs, a subset of patients develop breakthrough IFIs with substantial morbidity and mortality in this population. Here, we review the most significant risk factors for breakthrough IFIs in haematology patients, solid organ transplant recipients, and patients in the intensive care unit, focusing particularly on host factors, and highlight areas that require future investigation.

Idioma originalEnglish (US)
Páginas (desde-hasta)1021-1032
Número de páginas12
EstadoPublished - oct 1 2020

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases


Profundice en los temas de investigación de 'Breakthrough invasive fungal infections: Who is at risk?'. En conjunto forman una huella única.

Citar esto